Shemesh Yedida, Peles-Bortz Anat, Peled Yael, HarZahav Yedael, Lavee Jacob, Freimark Dov, Melnikov Semyon
Heart Institute, Sheba Medical Center, Tel Hashomer, Israel.
Nursing Management, Sheba Medical Center, Tel Hashomer, Israel.
Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13053. Epub 2017 Aug 19.
Nonadherence (NA) to immunosuppressive (IS) medications after organ transplant is a major risk factor for transplant failure, morbidity, and treatment costs. This study examined the association between feelings of indebtedness and guilt toward the donor, and IS medication adherence among HTx patients.
In this cross-sectional, descriptive, correlational study, a convenience sample of 102 HTx patients, from the outpatient facility of a tertiary medical center in Israel, completed the BAASIS, a validated instrument for assessing adherence, and reported their feelings of indebtedness and guilt toward the donor.
Missing a dose or skipping two or more doses, taking medication >2 hours before or after the recommended dosing time, altering the prescribed amount, or completely stopping the IS treatment in the last 4 weeks, characterized 64 patients (64%). The highest score received the item "timing nonadherence," characterizing 58 patients (56.9%). Age, waiting time, and time since transplant, guilt feelings, and indebtedness to donor explained 17% (R =.17) of the variance in adherence (χ =13.22, P=.021), with age, time since transplant, and guilt feelings significantly explaining adherence.
Physicians and nurses should inquire about the presence of guilt feelings, as they might be associated with NA to medications after HTx.
器官移植后免疫抑制(IS)药物治疗的不依从性(NA)是移植失败、发病和治疗成本的主要风险因素。本研究调查了心脏移植(HTx)患者对供体的亏欠感和内疚感与IS药物依从性之间的关联。
在这项横断面、描述性、相关性研究中,从以色列一家三级医疗中心的门诊设施中选取了102名HTx患者作为便利样本,他们完成了BAASIS(一种用于评估依从性的有效工具),并报告了他们对供体的亏欠感和内疚感。
在过去4周内,64名患者(64%)存在漏服一剂或漏服两剂及以上、在推荐给药时间之前或之后超过2小时服药、改变规定剂量或完全停止IS治疗的情况。得分最高的项目是“时间不依从”,有58名患者(56.9%)属于这种情况。年龄、等待时间、移植后的时间、内疚感以及对供体的亏欠感解释了依从性差异的17%(R = 0.17)(χ = 13.22,P = 0.021),其中年龄、移植后的时间和内疚感对依从性有显著影响。
医生和护士应询问患者是否有内疚感,因为这可能与HTx后药物治疗的不依从性有关。